Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one chemotherapy drug may kill more tumor
cells.
PURPOSE: Phase II trial to study the effectiveness of combining doxorubicin and ifosfamide in
treating patients who have metastatic kidney cancer.